Horowitz: The insanity of marketing mass vaccination to those already recovered from COVID
Aside from the government treating children as if they are at risk from this virus, the most consequentially unscientific policy from our government is the treatment of convalescent COVID patients as if they are not immune to the virus. Government has refused to lift any restrictions on those already infected and treats them as less immune than those who are vaccinated, still encouraging them to get the vaccine. In fact, the science says just the opposite.
Last week, even Jordan Peterson, a public figure admired by many people suspicious of the government-corporate monopoly, tweeted out that he is getting vaccinated because he believes his antibody levels from prior infection are too low to protect him.
This speaks to just how much the government and media have censored the information about T cells and how even a mild infection conveys long-term robust immunity against reinfection. One study found the immunity to last even 17 years later from SARS-1-infected patients who never even had COVID-19. Let's put aside the fact that the vaccines themselves have not been proven effective beyond a few months so far and thus would suffer the same perceived flaw of waning immunity as previous infection. The reality is that it's already proven that natural immunity is broader, more robust, and enduring than anything from a vaccine.
Even in vaccine-obsessed Israel, researchers from Tel Aviv University concluded that their research "puts into question the need to vaccinate recent (up to six month) previously-infected individuals." A study of 6.3 million Israelis showed that the estimated protection for those already infected was 94.8% from reinfection and 96.4% from severe illness, as compared to effectiveness of 92.8% and 94.4%, respectively, from the vaccines. There was just one death in the entire country of someone who supposedly already had the virus, and he was over 80 years old.
One of the challenges people foresaw with vaccines for a virus that mutates a lot like the flu is that the immunity against the spike protein might not work against mutant strains. But studies thus far have show that natural immunity is even more robust. A new preprint study from French researchers tested blood samples from health care workers who never had the virus but got both Pfizer shots against blood samples from those health care workers who had a previous mild infection and a third group of patients who had a serious case of COVID. They found, "No neutralisation escape could be feared concerning the two variants 53 of concern in both populations" of those previously infected. At the same time, the effectiveness of even prior mild infection against the South African variant appeared stronger than in those who had the Pfizer shots.